PEAR-004

· Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PEAR-004, covering 2020-11-23 to 2020-11-23. Get the full timeline:

Most recent: Clinical Trial Update: Study of Efficacy of PEAR-004 in Schizophrenia [Phase 2]